Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Journey Medical Corp 9237 E VIA DE VENTURA BLVD. SUITE 105 SCOTTSDALE AZ 85258 USA

www.jmcderm.com Employees: 58 P: 480-434-6670

Description:

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

Key Statistics

Overview:

Market Capitalization, $K 108,402
Enterprise Value, $K 95,582
Shares Outstanding, K 20,727
Annual Sales, $ 79,180 K
Annual Net Income, $ -3,850 K
Last Quarter Sales, $ 14,630 K
Last Quarter Net Income, $ -2,390 K
EBIT, $ -18,010 K
EBITDA, $ -10,660 K
60-Month Beta 0.92
% of Insider Shareholders 13.16%
% of Institutional Shareholders 7.25%
Float, K 17,999
% Float 86.84%
Short Volume Ratio 0.37

Growth:

1-Year Return 20.65%
3-Year Return -38.75%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -0.94
EPS Growth vs. Prev Qtr 29.41%
EPS Growth vs. Prev Year -115.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DERM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -132.10%
Return-on-Assets % -26.90%
Profit Margin % -4.86%
Debt/Equity 1.81
Price/Sales 1.40
Price/Cash Flow 29.53
Price/Book 10.15
Book Value/Share 0.53
Interest Coverage -1.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar